Unique endoscopy findings in collagenous colitis.
Couto
Gilberto
G
Gastroenterology Department, Hospitalar de Lisboa Ocidental, Lisbon, Portugal.
Bispo
Miguel
M
Barreiro
Pedro
P
Monteiro
Lucília
L
Matos
Leopoldo
L
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D002921:Cicatrix / Q000175:diagnosis / Q000473:pathology; D046729:Colitis, Collagenous / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D044684:Colon, Transverse / Q000473:pathology; D003113:Colonoscopy; D004359:Drug Therapy, Combination; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology; D007416:Intestinal Perforation / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D064747:Lansoprazole; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D013449:Sulfonamides; D064747:Lansoprazole; C012655:nimesulide